• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Report: $47.2B invested in Q3 2015; more than past 17 years

Report: $47.2B invested in Q3 2015; more than past 17 years

October 19, 2015 By Fink Densford

MoneyTree ReportVenture capitalists have dropped $16.3 billion on medtech in the 3rd quarter this year, bringing the total invested up to $47.2 billion so far this year, higher than the past 17 year totals, according to a MoneyTree Report.

The money this quarter went into 1,070 deals, according to the report from PricewaterhouseCooper and the National Venture Capital Association, down 5% from Q2 2015. The total deal count was down 11%.

This quarter marks the 7th consecutive quarter in which more than $10 billion has been invested in medtech, according to the report.

“With 7 consecutive quarters of more than $10 billion deployed to the startup ecosystem and more than half of all investment deals now going to seed or early stage companies, it’s a great time to be an entrepreneur in America. If there’s anything we learned this quarter, it’s that despite the recent turbulence in the financial markets, venture capitalists remain undeterred and are confident investing in truly innovative companies across all sectors of our economy. At $16.3 billion invested for the quarter and over $47 billion invested for the year, total venture capital dollars deployed to the startup ecosystem in 2015 is on target to be the second highest since the inception of the MoneyTree Report in 1995,” NVCA CEO Bobby Franklin said in a press release.

Software companies received the most funding of all the industries in medtech, with $5.8 billion and 512 deals this quarter. The top 10 deals from the quarter accounted for 19% of all funds invested.

Investments in seed-stage companies rose 23%, bringing in $214 million in 55 deals, while 1st-time financing dollars increased 7%, to $2.5 billion through 372 deals this quarter.

“Despite a modest downtick in dollars and deals in the third quarter, we are still in a midst of a robust market and this quarter marks the second highest quarter in aggregate investment dollars since the fourth quarter of 2000. Though software remains dominant, the top ten deals included rounds of funding across seven industries, illustrating continued investment appetite in new areas of innovation across industries,” PricewaterhouseCooper US venture capital market leader Tom Ciccolella said in prepared remarks.

Filed Under: Business/Financial News Tagged With: Venture Capital/Private Equity

More recent news

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • Ancora Heart reaches enrollment milestone in pivotal heart failure device trial
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Johnson & Johnson launches daily disposable multifocal toric contact lens
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy